Company Performance Metrics
Integralis Ltd, was founded by Prof. Michael Inbar PhD, in January 2006, with the goal of eveloping new strategies and products to help medical professionals in the assessment, monitoring and treatment of traumatic health conditions in Intensive Care Units(ICU). The company's first product is Ralis#1, which is designed to provide early
detection and monitoring of sepsis in Neonatal Intensive Care Units (NICU). Ralis#1 facilitates the enhanced treatment of premature infants with body weight of less than 1,500 g. The company's main asset is a multidisciplinary R&D team,comprised of physicians and biologists who collaborate with software and IT experts, to deliver a radically new method that facilitates the recording and display of vital body signs on standard monitors. The company owns all the required permits for marketing and sale of Ralis#1, in Europe.
